Investors & Media Press Releases

Axovant to Present at Two Upcoming Investor Conferences


BASEL, Switzerland, May 31, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ:AXON) today announced that Pavan Cheruvu, M.D., chief executive officer, will present a corporate overview at the Jefferies 2018 Global Healthcare Conference on June 7, 2018 at 9:00 a.m. ET, and at the JMP Securities Life Science Conference on June 21, 2018 at 9:00 a.m. ET.

A live webcast will be available for each conference in the Investors section of Axovant's website at A replay will be available for 30 days following each conference.

About Axovant Sciences

Axovant is a clinical-stage biopharmaceutical company dedicated to advancing innovative treatments for patients with serious neurologic and neuropsychiatric conditions. Axovant is committed to developing and commercializing a pipeline of product candidates by identifying and developing novel treatments for unmet needs in neurology and psychiatry.

For more information, visit



Tricia Truehart
(631) 892-7014


Paul Davis
(646) 495-5310

SOURCE Axovant Sciences

Primary Logo

Source: Axovant Sciences Ltd.